Probabilistic classification of anti-SARS-CoV-2 antibody responses improves seroprevalence estimates. (2022)
Attributed to:
Statistical ‘omics approaches to understanding autoimmune diseases
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/cti2.1379
PubMed Identifier: 35284072
Publication URI: http://europepmc.org/abstract/MED/35284072
Type: Journal Article/Review
Volume: 11
Parent Publication: Clinical & translational immunology
Issue: 3
ISSN: 2050-0068